Merit Medical Systems Inc (MMSI) stock
MMSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/309% below fair value
$85.93+1.44 (+1.70%)
Close on Nov 18, 2026Market cap $5.15BP/E 32.3Yield –
Merit Medical Systems revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Merit Medical Systems's revenue for the twelve months ending Sep 30, 2026 was $1.61B, up 9.1% year over year. For fiscal 2025 it was $1.52B, up 11.8% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is $1.52B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52B | +11.8% |
| FY2024 | Dec 31, 2024 | $1.36B | +7.9% |
| FY2023 | Dec 31, 2023 | $1.26B | +9.2% |
| FY2022 | Dec 31, 2022 | $1.15B | +7.1% |
| FY2021 | Dec 31, 2021 | $1.07B | +11.5% |
| FY2020 | Dec 31, 2020 | $963.88M | -3.1% |
| FY2019 | Dec 31, 2019 | $994.85M | +12.7% |
| FY2018 | Dec 31, 2018 | $882.75M | +21.3% |
| FY2017 | Dec 31, 2017 | $727.85M | +20.5% |
| FY2016 | Dec 31, 2016 | $603.84M | +11.4% |
| FY2015 | Dec 31, 2015 | $542.15M | +6.4% |
| FY2014 | Dec 31, 2014 | $509.69M | +13.5% |
| FY2013 | Dec 31, 2013 | $449.05M | +13.9% |
| FY2012 | Dec 31, 2012 | $394.29M | +9.7% |
| FY2011 | Dec 31, 2011 | $359.45M | +21.1% |
| FY2010 | Dec 31, 2010 | $296.76M | +15.3% |
| FY2009 | Dec 31, 2009 | $257.46M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $416.24M | +8.4% |
| Q2 FY2026 | Jun 30, 2026 | $418.84M | +9.5% |
| Q1 FY2026 | Mar 31, 2026 | $381.88M | +7.5% |
| Q4 FY2025 | Dec 31, 2025 | $393.94M | +10.9% |
| Q3 FY2025 | Sep 30, 2025 | $384.16M | +13.0% |
| Q2 FY2025 | Jun 30, 2025 | $382.46M | +13.2% |
| Q1 FY2025 | Mar 31, 2025 | $355.35M | +9.8% |
| Q4 FY2024 | Dec 31, 2024 | $355.16M | +9.4% |
| Q3 FY2024 | Sep 30, 2024 | $339.85M | +7.8% |
| Q2 FY2024 | Jun 30, 2024 | $338.00M | +5.6% |
| Q1 FY2024 | Mar 31, 2024 | $323.51M | +8.7% |
| Q4 FY2023 | Dec 31, 2023 | $324.52M | +10.6% |
| Q3 FY2023 | Sep 30, 2023 | $315.23M | +9.8% |
| Q2 FY2023 | Jun 30, 2023 | $320.06M | +8.5% |
| Q1 FY2023 | Mar 31, 2023 | $297.57M | +8.0% |
| Q4 FY2022 | Dec 31, 2022 | $293.42M | +5.4% |
| Q3 FY2022 | Sep 30, 2022 | $287.18M | +7.5% |
| Q2 FY2022 | Jun 30, 2022 | $294.98M | +5.2% |
| Q1 FY2022 | Mar 31, 2022 | $275.42M | +10.6% |
| Q4 FY2021 | Dec 31, 2021 | $278.49M | +7.9% |
| Q3 FY2021 | Sep 30, 2021 | $267.02M | +9.4% |
| Q2 FY2021 | Jun 30, 2021 | $280.33M | +28.4% |
| Q1 FY2021 | Mar 31, 2021 | $248.91M | +2.2% |
| Q4 FY2020 | Dec 31, 2020 | $258.00M | +0.0% |
| Q3 FY2020 | Sep 30, 2020 | $243.98M | +0.4% |
| Q2 FY2020 | Jun 30, 2020 | $218.37M | -14.5% |
| Q1 FY2020 | Mar 31, 2020 | $243.53M | +2.2% |
| Q4 FY2019 | Dec 31, 2019 | $257.92M | +10.6% |
| Q3 FY2019 | Sep 30, 2019 | $243.05M | +9.6% |
| Q2 FY2019 | Jun 30, 2019 | $255.53M | +13.7% |
| Q1 FY2019 | Mar 31, 2019 | $238.35M | +17.4% |
| Q4 FY2018 | Dec 31, 2018 | $233.25M | +22.2% |
| Q3 FY2018 | Sep 30, 2018 | $221.66M | +23.6% |
| Q2 FY2018 | Jun 30, 2018 | $224.81M | +20.5% |
| Q1 FY2018 | Mar 31, 2018 | $203.04M | +18.7% |
| Q4 FY2017 | Dec 31, 2017 | $190.90M | +21.0% |
| Q3 FY2017 | Sep 30, 2017 | $179.34M | – |
| Q2 FY2017 | Jun 30, 2017 | $186.55M | – |
| Q1 FY2017 | Mar 31, 2017 | $171.07M | – |
| Q4 FY2016 | Dec 31, 2016 | $157.72M | – |
See a number that looks wrong?